1693PEfficacy and safety of anlotinib in advanced leiomyosarcoma: Subgroup analysis of a phase IIB trial (ALTER0203) Y Chi, Y Yao,Z Fang,S Wang, G Huang,Q Cai,G Shang,G Wang, G Qu,Q Wu, Y Jiang,J Song, J Chen,X Zhu,Z Cai, C Bai, Y Lu,Z Yu,J Shen, J CaiANNALS OF ONCOLOGY（2019）引用 2|浏览33暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
